LY-354740 (Eli Lilly)
- PMID: 12789623
LY-354740 (Eli Lilly)
Abstract
Lilly is developing LY-354740, the lead compound in a series of derivatives of the metabotropic glutamate receptor group II agonist L-CCG-1, for the potential treatment of anxiety [212536], [276941], [276942].